Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 96-106

  Chatham, John C ^a   Gao, Zhi Ping ^a   Bonen, Arend ^b   Forder, John R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Cardiomyopathy; Diabetes; Energy metabolism; NMR; Ventricular function

Indexed keywords

LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIOMYOPATHY; DIABETES MELLITUS; ENERGY METABOLISM; ENZYME INHIBITION; GLUCOSE OXIDATION; GLYCOLYSIS; HEART FUNCTION; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIUM; OXIDATION-REDUCTION; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033001171     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00056-5     Document Type: Article

References (50)

1. Uusitupa M.I.J., Niskanen L.K., Siitonen O., Voutilainen E., Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type-2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 36:1993;1175-1184.
2. Ho K.K.L., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure-The Framingham Study. J Am Coll Cardiol. 22:1993;A6-A13.
3. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of Type-1 Diabetes mellitus and its complications. N Engl J Med. 317:1987;1390-1398.
4. Mustonen J.N., Uusitupa M.I.J., Laakso M., et al. Left ventricular systolic function in middle-aged patients with Diabetes mellitus. Am J Cardiol. 73:1994;1202-1208.
5. Lehto S., Pyorala K., Miettinen H., et al. Myocardial infarct size and mortality in patients with noninsulin-dependent Diabetes mellitus. J Intern Med. 236:1994;291-297.
6. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: The Framingham Study. Am J Cardiol. 34:1974;29-34.
7. Kannel W.B., McGee D.L. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation. 59:1979;8-13.
8. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease: The Framingham Study. J Am Med Assoc. 241:1979;2035-2038.
9. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose fatty-acid cycle: Its role in insulin sensitivity and metabolic disturbances of Diabetes mellitus. Lancet. 1:1963;785-789.
10. Rodrigues B., McNeill J.H. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 26:1992;913-922.
11. Taegtmeyer H., Passmore J.M. Defective energy metabolism of the heart in diabetes. The Lancet. 1:1985;139-141.
12. Chatham J.C. The effect of diabetes on myocardial glucose metabolism. Chatham J.C., Forder J.R., McNeill J.H. The heart in diabetes. 1996;215-251 Kluwer Academic Publishers, Norwell, MA.
13. Lopaschuk G.D. Fatty acid metabolism in the heart following diabetes. Chatham J.C., Forder J.R., McNeill J.H. The heart in diabetes. 1996;215-251 Kluwer Academic Publishers, Norwell, MA.
14. van der Vusse G.J., de Groot M.J.M. Interrelationship between lactate and cardiac fatty acid metabolism. Mol Cell Biochem. 116:1992;11-17.
15. Drake A.J., Haines J.R., Noble I.M. Preferential uptake of lactate by the normal myocardium in dogs. Cardiovasc Res. 14:1980;65-72.
16. 13C isotope isomers. Am J Physiol. 259:1990;H987-H995.
17. 13C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy. J Mol Cell Cardiol. 25:1993;1203-1213.
18. 13C-labeling of citrate released by perfused rat hearts. J Biol Chem. 272:1997.
19. Braasch W., Gudbjarnason S., Puri P.S., Ravens K.G., Bing R.J. Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anesthetized dogs. Circ Res. 23:1968;429-438.
20. Bergmeyer H.U., Bergmeyer J., Grassl M. Methods of enzymatic analysis. Third Edition :1985;VCH Verlagsgesellschaft, Weinheim, Germany.
21. McCullagh K.J.A., Poole R.C., Halestrap A.P., O'Brien M., Bonen A. The role of lactate transporter (MCT1) in skeletal muscles. Am J Physiol. 271:1996;E143-E150.
22. Baker S.K., McCullagh K.J.A., Bonen A. Training intensity dependent and tissue specific increases in lactate uptake and MCT1 in heart and muscle. J Appl Physiol. 84:1998;987-994.
23. Garcia C.K., Goldstein J.L., Pathak R.K., Anderson G.W., Brown M.S. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell. 76:1994;865-873.
24. McCullagh K.J.A., Poole R.C., Halestrap A.P., et al. Chronic electrical stimulation increases MCT1 and lactate uptake in red and white skeletal muscle. Am J Physiol. 273:1997;E239-E246.
25. Thorling E.B., Jensen K. The lactate dehydrogenase isoenzymes in various organs of the rabbit in anaemia, hypoxia, and after cobalt administration. Acta Pathol Microbiol Scand. 66:1966;426-436.
26. Chatham J.C., Forder J.F. The relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol. 273:1997;H52-H58.
27. Hall J.L., Stanley W.C., Lopaschuk G.D., et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol. 271:1996;H2320-H2329.
28. Pierce G.N., Beamish R.E., Dhalla N.S. Heart dysfunction in diabetes. 1988;CRC Press, Boca Raton, FL.
29. Liu M.S., Spitzer J.J. Fatty acid and lactate metabolism by heart homogenates from alloxan-diabetic dogs. Horm Metab Res. 10:1978;114-117.
30. Chen V.G., Bagby J., Spitzer J.J. Exogenous substrate utilization by isolated myocytes from chronically diabetic rats. Am J Physiol. 245:1983;C46-C51.
31. Gertz E.W., Wisneski J.A., Stanley W.C., Neese R.A. Myocardial substrate utilization during exercise in humans: Dual carbon-labelled carbohydrate isotope experiments. J Clin Invest. 82:1988;2017-2025.
32. Kaplan N.O., Everse J. Regulatory characteristics of lactate dehydrogenases. Adv Enzy Regul. 10:1972;323-336.
33. Ramasamy R., Oates P.J., Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes. 46:1997;292-300.
34. Puckett S.W., Reddy W.J. A decrease in the malate-aspartate shuttle and glutamate translocase activity in heart mitochondria from alloxan-diabetic rats. J Mol Cell Cardiol. 11:1979;173-187.
35. Williamson J.R., Chang K., Frangos M., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813.
36. Tilton R.G., Chang K., Nyengaard J.R., et al. Inhibition of sorbital dehydrogenase: effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats. Diabetes. 44:1995;234-242.
37. Ramasamy R., Trueblood N., Schaefer S. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion. Am J Physiol. 275:1998;H195-H203.
38. Trueblood N., Ramasamy R. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol. 275:1998;H75-83.
39. Randle P.J., Newsholme E.A., Garland P.B. Regulation of glucose uptake by muscle 8: Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J. 93:1964;652-665.
40. Neely J.R., Bowman R.H., Morgan H.E. Effects of ventricular pressure development and palmitate on glucose transport. Am J Physiol. 216:1969;804-811.
41. Fischer Y., Bottcher U., Eblenkamp M., et al. Glucose transport and glucose transporter GLUT4 are regulated by product(s) of intermediary metabolism in cardiomyocytes. Biochem J. 321:1997;629-638.
42. Laughlin M.R., Taylor J., Chesnick A.S., Balaban R.S. Nonglucose substrates increase glycogen synthesis in vivo in dog heart. Am J Physiol. 267:1994;H217-H223.
43. Garland P.B., Newsholme E.A., Randle P.J. Regulation of glucose uptake by muscle. 9: Effects of fatty acids, ketone bodies and of alloxan-diabetes and starvation, on pyruvate metabolism and on lactate/pyruvate and l-glycerol 3-phosphate/dihydroxyacetone phosphate concentration ratios in rat heart and rat diaphragm muscles. Biochem J. 93:1964;664-678.
44. Gamble J., Lopaschuk G.D. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta. 1225:1994;191-199.
45. Chua B.H.L. Specificity of leucine effect on protein degradation in perfused rat heart. J Mol Cell Cardiol. 26:1994;743-751.
46. Miller T.B., Praderio M., Wolleben C., Bullman J. A hypersensitivity of glycogen phosphorylase activation in hearts of diabetic rats. J Biol Chem. 256:1981;1748-1753.
47. Paulson D.J., Crass M.F. Endogenous triacyglyerol metabolism in the diabetic heart. Am J Physiol. 242:1982;H1084-H1094.
48. Murthy V.K., Bauman M.D., Shipp J.C. Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes. 32:1983;718-722.
49. Wall S.R., Lopaschuk G.D. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta. 1006:1989;97-103.
50. Chatham J.C., Gao Z-P, Forder J.R. The effects of exogenous palmitate on lactate and palmitate oxidation in hearts from normal and diabetic rats. Am J Physiol 1998: submitted.